Hereditary vascular retinopathy

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

3 events
May 2024A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)

Kodiak Sciences Inc — PHASE3

TrialACTIVE NOT RECRUITING
Jan 2022Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

AbbVie — PHASE3

TrialRECRUITING
Dec 2020Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

AbbVie — PHASE2, PHASE3

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Hereditary vascular retinopathy.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Hereditary vascular retinopathy.
Search all trials →
Search clinical trials for Hereditary vascular retinopathy

Recent News & Research

No recent news articles indexed yet for Hereditary vascular retinopathy.
Search PubMed for Hereditary vascular retinopathy

Browse all Hereditary vascular retinopathy news →

Specialist Network

Top 6 by expertise

View all Hereditary vascular retinopathy specialists →

Quick Actions